申请人:British Biotech Pharmaceuticals, Ltd.
公开号:US05840939A1
公开(公告)日:1998-11-24
Compounds of formula (I), wherein X is a --CO.sub.2 H or --CONHOH group; ##STR1## R.sub.4 is a group --CHR.sup.x R.sup.y wherein R.sup.x and R.sup.y independently represent optionally substituted phenyl or monocyclic heteroaryl rings, which optionally may be linked covalently to each other by a bond or by a C.sub.1 -C.sub.4 alkylene or C.sub.2 -C.sub.4 alkenylene bridge; and R.sub.1, R.sub.2, R.sub.3 and R.sub.5 as defined in the specification are selective inhibitors of stromelysin-1 and matrilysin relative to human fibroblast collagenase and 72 KDa gelatinase.
化合物的式子(I),其中X是--CO.sub.2 H或--CONHOH基团; ## STR1 ## R.sub.4是一个--CHR.sup.x R.sup.y基团,其中R.sup.x和R.sup.y分别表示可选取代的苯基或单环杂环环,它们可以选择性地通过键或C.sub.1-C.sub.4烷基或C.sub.2-C.sub.4烯基桥链共价连接在一起; 而R.sub.1,R.sub.2,R.sub.3和R.sub.5在说明书中的定义是选择性地抑制stromelysin-1和matrilysin相对于人类成纤维细胞胶原酶和72 KDa明胶酶。